📦 Free Express Shipping on orders over $150 — Australia-wide
💎 Save up to 22%

Retatrutide & Cagrilintide Blend 12.5mg (10mg/2.5mg)

$295.90 inc. GST


✓ Verified BVR 99.37% + 99.13% Purity No Fillers Free Reship Guarantee
High-purity dual-peptide analytical reference blend combining Retatrutide (99.37% HPLC, 10mg, CAS 2381089-83-2, 4731.40 Da) and Cagrilintide (99.13% HPLC, 2.5mg, CAS 1415456-99-3, 4409.00 Da) in a single 12.5mg filler-free vial. Each vial includes a Batch Verification Report with full analytical data for both components including HPLC, ESI-MS, amino acid analysis, and endotoxin testing, plus a batch-specific QR code for instant documentation access. Australian supplier with fast domestic shipping. If your order doesn’t arrive, we reship free. Research use only.

SKU: AV-B202 Category:

Analytical Reference Standard — Dual Peptide Blend

Retatrutide & Cagrilintide Blend

High-purity dual-peptide analytical reference blend — 10mg Retatrutide + 2.5mg Cagrilintide (12.5mg total) in a single filler-free vial with comprehensive documentation for both components

Pre-Order
Coming Soon — Secure your order now. You will be charged at time of purchase and your order will ship as soon as stock arrives.
12.5mg
Total Content
10mg + 2.5mg blend
99.37%
Reta HPLC Purity
BVR verified
99.13%
Cagri HPLC Purity
BVR verified
0%
Fillers Added
No mannitol or bulking
Batch Verification Report (BVR)
Dual-Component Analytical Data
Australian Laboratory Supply
No Fillers or Bulking Agents

Product Overview

Aventris Labs supplies this research-grade Retatrutide & Cagrilintide dual-peptide blend as an analytical reference standard. Each vial contains 10mg Retatrutide (CAS 2381089-83-2, synthetic 39-amino acid peptide with C20 diacid fatty acid modification, 4731.33 Da) and 2.5mg Cagrilintide (CAS 1415456-99-3, synthetic 39-amino acid acylated peptide with eicosanedioic acid modification and Cys3–Cys8 disulfide bridge, 4409.10 Da). Both components manufactured using solid-phase peptide synthesis (SPPS) with comprehensive analytical verification.

Primary applications: Reference standard for method development, analytical validation, peptide characterisation studies, and comparative quality control.

Documentation Included

  • Batch Verification Report (BVR) – Complete batch-specific analytical data for both peptide components compiled by Aventris Labs
  • HPLC chromatography – Retatrutide 99.37% purity / Cagrilintide 99.13% purity with retention time data
  • Mass spectrometry (ESI-MS) – Molecular weight confirmation for both components (Reta: 4731.40 Da / Cagri: 4409.00 Da)
  • Peptide content assay – Retatrutide 92.19% / Cagrilintide 95.49% by nitrogen analysis
  • Assay (HPLC) – Retatrutide 99.45% / Cagrilintide 103.14% on anhydrous, salt-free basis
  • Amino acid analysis – Complete composition verification for both peptides
  • Karl Fischer water content – Retatrutide 3.58% / Cagrilintide 2.96%
  • Residual solvents results – All solvents below detection limits (both components)
  • Microbial limits results – Total aerobic and yeast/mold counts compliant (both components)
  • Bacterial endotoxins – Both components conform (<10EU/mg)
  • Batch verification portal – QR code and online lookup system

Analytical Data (Batch Verification Report)

The following data represents typical batch results for each component. Your batch-specific values are available in your Batch Verification Report (BVR) via the verification portal.

Component 1 — Retatrutide (10mg)

Parameter Result Specification Status
Purity (HPLC) 99.37% ≥98.0% PASS
Peptide Content 92.19% ≥85.0% PASS
Molecular Weight (ESI-MS) 4731.40 Da 4731.33 ±1.0 PASS
Assay (HPLC) 99.45% 95.0-105.0% PASS
Water Content (Karl Fischer) 3.58% ≤10.0% PASS
pH (5.0mg/mL) 7.25 6.0-8.0 PASS
Solubility (water) Conforms ≥30mg/mL PASS
Acetate Content N.D. ≤15.0% PASS
TFA Content N.D. ≤0.5% PASS
Sodium Salt 1.79% <5.0% PASS
Bacterial Endotoxins Conforms <10EU/mg PASS
Microbial Limits Conforms Per specification PASS

Component 2 — Cagrilintide (2.5mg)

Parameter Result Specification Status
Purity (HPLC) 99.13% ≥99.0% PASS
Related Substances (Total) 0.87% ≤1.0% PASS
Related Substances (Individual) 0.39% ≤0.5% PASS
Peptide Content 95.49% ≥85.0% PASS
Molecular Weight (ESI-MS) 4409.00 Da 4409.10 ±1.0 PASS
Assay (HPLC) 103.14% 95.0-105.0% PASS
Water Content (Karl Fischer) 2.96% ≤10.0% PASS
Acetate Content 4.62% ≤12.0% PASS
TFA Content N.D. ≤0.25% PASS
High Molecular Protein N.D. ≤0.5% PASS
Bacterial Endotoxins Conforms <10EU/mg PASS
Microbial Limits Conforms Per specification PASS

Residual Solvents Results (Both Components)

Solvent Retatrutide Cagrilintide Limit Status
Acetonitrile N.D. N.D. ≤410ppm PASS
Methanol N.D. N.D. ≤3000ppm PASS
Methylene Chloride N.D. N.D. ≤600ppm PASS
N,N-Dimethylformamide N.D. N.D. ≤880ppm PASS
Isopropyl Ether N.D. N.D. ≤5000ppm PASS

Amino Acid Analysis — Cagrilintide Component

Amino Acid Result Specification Status
His 0.88 0.8-1.2 PASS
Asp 4.14 4.0-6.0 PASS
Arg 2.38 1.6-2.4 PASS
Lys 0.95 0.8-1.2 PASS
Ile 1.08 0.8-1.2 PASS
Leu 3.21 2.4-3.6 PASS
Val 1.08 0.8-1.2 PASS
Thr 4.71 4.0-6.0 PASS
Phe 2.39 1.6-2.4 PASS
Ser 3.02 2.4-3.6 PASS
Ala 2.82 2.4-3.6 PASS
Gly 2.19 1.6-2.4 PASS
Glu 2.95 2.4-3.6 PASS
Pro 4.18 3.2-4.8 PASS

Peptide Sequences

Retatrutide

Tyr-{Aib}-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{α-Me-Leu}-Leu-Asp-Lys-{diacid-C20-γ-Glu-(AEEA)-Lys}-Ala-Gln-{Aib}-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH₂

Cagrilintide

Eicosanedioic acid-γ-Glu-Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Glu-Phe-Leu-Arg-His-Ser-Ser-Asn-Asn-Phe-Gly-Pro-Ile-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Pro-NH₂
(Disulfide bridge: Cys3–Cys8)
Molecular Identity
Retatrutide Cagrilintide
Sequence Length 39 amino acids + C20 diacid fatty acid modification 39 amino acids + eicosanedioic acid modification + disulfide bridge
Molecular Formula C₂₂₁H₃₄₂N₄₆O₆₈ C₁₉₄H₃₁₂N₅₄O₅₉S₂
Molecular Weight 4731.33 Da (theoretical) / 4731.40 Da (observed) 4409.10 Da (theoretical) / 4409.00 Da (observed)
CAS Number 2381089-83-2 1415456-99-3
Source Synthetic peptide (SPPS)

Ordering Information

📦

Package Contents

12.5mg total (10mg Retatrutide + 2.5mg Cagrilintide) lyophilized powder blend in sealed glass vial with batch-specific labeling and QR verification code. No fillers, mannitol, or bulking agents added.

📄

Batch Verification Report

Complete BVR with analytical data for both peptide components accessible via QR code scan, email link, or online verification portal at aventrislabs.com/verify.

🚚

Australian Express Shipping

Fast domestic express shipping Australia-wide. Pre-order now — your order will ship as soon as stock arrives. If your order doesn’t arrive, we reship free — no questions asked.

💰

Tier Pricing Available

Volume discounts for research facilities and repeat orders. Contact for institutional pricing and bulk quantities.

Quality & Verification

Batch Verification Report (BVR)

Every batch includes comprehensive analytical documentation for both blend components through Aventris Labs’ verification system, presenting all manufacturer analytical data in a standardised format for full transparency.

🔬

Filler-Free Guarantee

Aventris peptides contain zero fillers. No mannitol, no bulking agents — just pure lyophilized peptide blend. The powder may appear smaller than competitors’ products because there’s nothing added to artificially increase volume.

🔗

Online Verification Portal

Instant batch verification via QR code or manual lookup. Access your batch-specific BVR anytime at aventrislabs.com/verify.

🇦🇺

Australian Laboratory Supply

Aventris Labs is an Australian supplier providing research-grade peptide reference materials to universities and biotech laboratories nationwide.

Complete Specifications

Product Name Retatrutide & Cagrilintide Blend
SKU AVX-FO64L0-13
Description Dual-peptide analytical reference blend — two synthetic 39-amino acid acylated peptides with distinct fatty acid modifications
Blend Composition 10mg Retatrutide + 2.5mg Cagrilintide (12.5mg total per vial)
Physical Form White to off-white lyophilized powder
Amount per Vial 12.5mg total (net peptide content)

Retatrutide Component

CAS Number 2381089-83-2
Molecular Formula C₂₂₁H₃₄₂N₄₆O₆₈
Molecular Weight 4731.33 Da (ESI-MS verified: 4731.40 Da)
Sequence Length 39 amino acids with C20 diacid fatty acid modification
Purity (HPLC) 99.37% (typical, ≥98% specification)
Peptide Content 92.19% (typical, ≥85% specification)
Assay (HPLC) 99.45% (typical, 95-105% specification)
Water Content 3.58% (typical, ≤10% specification)

Cagrilintide Component

CAS Number 1415456-99-3
Molecular Formula C₁₉₄H₃₁₂N₅₄O₅₉S₂
Molecular Weight 4409.10 Da (ESI-MS verified: 4409.00 Da)
Sequence Length 39 amino acids with eicosanedioic acid modification + Cys3–Cys8 disulfide bridge
Purity (HPLC) 99.13% (typical, ≥99% specification)
Peptide Content 95.49% (typical, ≥85% specification)
Assay (HPLC) 103.14% (typical, 95-105% specification)
Water Content 2.96% (typical, ≤10% specification)
Solubility Both components soluble in water
Storage Conditions Cool, dry place protected from light; -20°C for extended storage
Shelf Life 24 months when stored properly (retest date on BVR)
Intended Use Analytical Reference Standard / Research Use Only
Regulatory Status Not for human or veterinary use; laboratory research only

Frequently Asked Questions

Product Specifications

What is this blend?

This is a dual-peptide analytical reference blend containing two synthetic 39-amino acid acylated peptides: Retatrutide (10mg, CAS 2381089-83-2, C₂₂₁H₃₄₂N₄₆O₆₈, 4731.33 Da) with C20 diacid fatty acid modification, and Cagrilintide (2.5mg, CAS 1415456-99-3, C₁₉₄H₃₁₂N₅₄O₅₉S₂, 4409.10 Da) with eicosanedioic acid modification and a Cys3–Cys8 disulfide bridge. This product is supplied strictly as an analytical reference standard for laboratory research.

What analytical data is provided?

Each batch includes a comprehensive Batch Verification Report (BVR) containing manufacturer analytical data for both peptide components: HPLC purity (Reta 99.37% / Cagri 99.13%), peptide content (Reta 92.19% / Cagri 95.49%), ESI-MS molecular weight confirmation, assay results (Reta 99.45% / Cagri 103.14%), amino acid analysis, Karl Fischer water content, pH measurement, solubility confirmation, residual solvents results, bacterial endotoxins, and microbial limits results. Access via QR code or online verification portal.

How do I verify my batch?

Three methods: (1) Scan QR code on product label, (2) Click verification link in order confirmation email, (3) Visit aventrislabs.com/verify and enter batch ID. All provide instant access to your batch-specific Batch Verification Report with complete analytical data for both blend components.

Why does the powder look smaller than other suppliers?

Aventris peptides are filler-free. Many suppliers add mannitol or other bulking agents to make the powder appear larger in the vial. Our vials contain only pure lyophilized peptide — nothing else. Less visible powder actually means a purer product with no unnecessary additives. Learn more at aventrislabs.com/peptide-fillers-explained.

What is the shelf life?

Typically 24 months when stored in sealed vial at -20°C or below, protected from light and moisture. Specific retest date listed on Batch Verification Report.

What are the CAS numbers?

Retatrutide: CAS 2381089-83-2 (MW 4731.33 Da, C₂₂₁H₃₄₂N₄₆O₆₈). Cagrilintide: CAS 1415456-99-3 (MW 4409.10 Da, C₁₉₄H₃₁₂N₅₄O₅₉S₂). Both confirmed in the Batch Verification Report.

Is this a pre-order product?

Yes. This product is currently available for pre-order. You will be charged at time of purchase and your order will ship as soon as stock arrives. Pre-ordering secures your allocation.

Regulatory & Compliance

What is the regulatory status?

Both Retatrutide and Cagrilintide are supplied for research use only. They are NOT approved for human consumption, therapeutic use, veterinary applications, or diagnostic procedures. Purchasers are responsible for ensuring compliance with all applicable regulations.

Does Aventris provide research protocols or application guidance?

No. Aventris supplies analytical reference materials only. We do not provide reconstitution protocols, application methods, dosing information, or research design guidance. Researchers must develop protocols based on scientific literature and appropriate oversight. For technical science questions, resources such as Grok AI can assist with research-level inquiries.

Regulatory Disclaimer – Analytical Reference Material

⚠️

Retatrutide & Cagrilintide Blend is supplied as an analytical reference standard for research use only.

NOT for:

  • Human consumption, administration, or therapeutic use
  • Veterinary or animal health applications
  • Diagnostic procedures
  • Clinical trials or medical research involving human subjects (without appropriate approvals)
  • Food, cosmetic, or dietary supplement applications
  • Personal or consumer use of any kind

Purchaser Responsibilities:

  • Verify compliance with all applicable federal, state, and local regulations
  • Maintain proper laboratory safety and handling procedures
  • Ensure appropriate storage, documentation, and chain of custody
  • Use only for legitimate analytical/research purposes as intended

Aventris Labs Does NOT Provide:

  • Medical, therapeutic, or health-related advice
  • Dosing recommendations or administration protocols
  • Reconstitution instructions or methods
  • Research design or experimental methodologies

Pre-Order Retatrutide & Cagrilintide Blend

High-purity dual-peptide analytical reference blend (12.5mg total). Every order includes complete Batch Verification Report (BVR) with analytical data for both components, batch verification portal access, filler-free guarantee, and Australian domestic express shipping with free reship guarantee.

99.37% + 99.13% HPLC Purity
Complete Dual-Component BVR
Filler-Free
Free Reship Guarantee


Scroll to Top